Navigating Shareholder Litigation Risk in the Life Sciences Sector
Risk & Insurance - Mar 02, 2026
From clinical trial readouts to regulatory uncertainty, life science companies face unique D&O exposures at every stage of development — but disciplined practices and specialized insurance support can help mitigate the risk. The post Navigating Shareholder Litigation Risk in the Life Sciences S...
Recommended Articles
Posted: Mar 02, 2026
As acute mental health cases surge and legal exposure grows, carriers are facing unprecedented chall...
Posted: Feb 28, 2026
IASA Xchange offers focused education for every stage of your career, from the OnPOINT executive pro...
Posted: Feb 27, 2026
The latest people news in the industry today. The post Hinterland Insurance Appoints Kristine Hardy...